From reviewing the biomarker studies, although urine is a perfect liquid biopsy and BC is at the forefront of biomarker development, inclusion of a biomarker in clinical practice will require that such a biomarker is far superior to PSA, and at least non-inferior to cystoscopy. This evidence concerns the gene KLK3 and breast cancer.